MiNK Therapeutics, Inc.INKTNASDAQ
Loading
Current Ratio Over TimeFair Value
Percentile Rank60
3Y CAGR-33.2%
5Y CAGR+42.1%
Studio
Year-over-Year Change

Current ratio (current assets / current liabilities)

3Y CAGR
-33.2%/yr
Annual compound
5Y CAGR
+42.1%/yr
Recent deceleration
Percentile
P60
Within normal range
vs 5Y Ago
5.8x
Strong expansion
Streak
1 yr
Consecutive growthFair Value
PeriodValueYoY Change
20240.72+127.1%
20230.32-80.4%
20221.61-33.2%
20212.41+862.3%
20200.25+102.1%
20190.12-